Jagiellonskie Centrum Innowacji Sp. z o.o. — Clinical Trial Site

36 Registered trials

14 Currently recruiting

Organisation

Jagiellonskie Centrum Innowacji Sp. z o.o.

Location

Cracow, Poland

Identifier

ORG-100021192

Address

Ul. Profesora Michala Bobrzynskiego 14, 30-348, Poland

Departments

Centrum Badań Klinicznych
Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji
Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o.
Centrum Badan Klinicznych Jagiellonskiego Centrum Innowacji
Centrum Badań Klinicznych JCI
Centrum Badań Klinicznych, Jagielońskie Centrum Innowacji Sp. z o.o.
Dermatology
N/A
N/D
NA
Oddział Onkologii Klinicznej
Oncology
Orthopedics
PO001
Poradnia Onkologiczna

Clinical trials at this site (36)

Search interface

The effects of 2-week long treatment with naproxen sodium (Nalgesin® Forte) on synovial fluid cytokine and naproxen concentration and clinic… Ended

2023-505875-56-00 Knee osteoarthritis 6 2025-05-21
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months Ended

2022-502022-41-00 Acute lower respiratory infection 3 2024-05-28
Study on immunogenicity and safety of a meningococcal ACYW conjugate vaccine in healthy infants and toddlers Ended

2023-508177-85-00 Healthy volunteers (Meningococcal infection) 5 2024-03-12
Part C of A Phase 1b/2a Study of LY2880070 in Patients with Advanced or Metastatic Cancer Ended

2023-503459-91-00 Advanced or Metastatic Cancer 4 2023-11-21
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended

2022-502196-31-00 Advanced or Recurrent Endometrial Cancer 10 2023-08-21
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 1… Ended

2022-502023-21-00 Prevention of pregnancy 5 2023-07-12
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hype… Ended

2022-503022-13-00 Hypertriglyceridemia, Cardiovascular Diseases, Atherosc 5 2023-06-08
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENT… Ended

2023-510446-24-00 Cancer cachexia 4 2023-05-30
Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 5 2022-08-10
MENACWY=MEN7B-003 Ended

2023-506449-40-00 Infections, Meningococcal 9 2021-11-29
Study of IMG-007 in Participants with Moderate to Severe Atopic Dermatitis Ended

2023-505735-13-01 Atopic dermatitis 9
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5